Innophos to share in-vitro study results on Chelamax chelated magnesium at SupplySide West 2024
Innophos will also highlight the latest research findings on chelated minerals.
Image courtesy of Innophos
In a recent press release, Innophos announced it will present new in vitro research on the benefits of chelated minerals at SupplySide West in Las Vegas, NV. Led by Robert Finn, PhD, nutrition R&D director for Innophos, the presentation will take place at a Breakfast Brief on Wednesday, October 30, from 9 to 10 a.m. where he will explain the higher absorption of Chelamax Magnesium products and maximizing magnesium for absorption in tablets, capsules, and gummies.
"Innophos is leading the way in advancing the science of chelated minerals,” stated Dr. Finn, in the press release. “Our latest in vitro study confirms the superior absorption rates of Chelamax chelated magnesium. I am excited to meet with attendees and share our new findings.”
Innophos will be at Booth #3880 and will showcase their three-step verification process for confirming full mineral chelation, plus the bioaccessibility and bioavailability offered by organically bound minerals. They will also introduce their whitepaper on their latest research.
FDA revokes authorization to use Red No. 3 as a color additive in food or drugs
January 15th 2025FDA contends that the color additive is safe for humans but is legally obligated by the Delaney Clause of the FD&C act to revoke authorization as research shows the Red No. 3 induces cancer in rats.
